Search

everythinglearnresearchcommunity

for

Search:↓

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The new drug delivery system improves exemestane's absorption and effectiveness.

The method effectively showed that the two exemestane preparations are bioequivalent.

Aromatase inhibitors can cause skin issues, especially with anastrozole and exemestane, so monitoring is important.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Hair loss is a common side effect of hormone treatments for cancer.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Including androgens in hormone therapy may lower breast cancer risk.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Researchers developed a method to detect hormone-blocking drugs in wastewater and found them in Beijing's sewage, suggesting they can survive sewage treatment.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Estrogen alone can lower testosterone in some transfeminine people.

The FDA did not approve a testosterone drug because of safety concerns.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

The FDA rejected a testosterone drug again due to safety concerns.

Estrogen treatments can cause unwanted effects in men and should be used cautiously.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.